Published in Cancer Weekly, February 18th, 2003
"All of the myeloma cell lines we tested express both N-ras and K-ras, but not H-ras. GTP bound ras was measured and the percentage of the total Ras pool that was activated in response to IL-6 was calculated. IL-6 is able to transiently activate both N and K-ras in the ANBL6 cell tine.
"In addition, increasing concentrations...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2003-02-18)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.